Joke Bilcke

3.4k total citations
73 papers, 2.0k citations indexed

About

Joke Bilcke is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Joke Bilcke has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 31 papers in Infectious Diseases and 14 papers in Hepatology. Recurrent topics in Joke Bilcke's work include Viral gastroenteritis research and epidemiology (22 papers), Hepatitis Viruses Studies and Epidemiology (14 papers) and Respiratory viral infections research (14 papers). Joke Bilcke is often cited by papers focused on Viral gastroenteritis research and epidemiology (22 papers), Hepatitis Viruses Studies and Epidemiology (14 papers) and Respiratory viral infections research (14 papers). Joke Bilcke collaborates with scholars based in Belgium, United Kingdom and Australia. Joke Bilcke's co-authors include Philippe Beutels, Pierre Van Damme, Mark Jit, Lander Willem, Niel Hens, Marc Van Ranst, Marina Antillón, Jelle Matthijnssens, Mark Zeller and Marc Brisson and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Joke Bilcke

70 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joke Bilcke Belgium 26 792 738 347 335 226 73 2.0k
Judith Koch Germany 26 1.3k 1.6× 442 0.6× 444 1.3× 202 0.6× 109 0.5× 86 2.1k
Daniel R. Feikin United States 35 1.6k 2.0× 1.2k 1.6× 192 0.6× 350 1.0× 50 0.2× 66 3.5k
Virginia E. Pitzer United States 38 2.7k 3.4× 1.3k 1.7× 535 1.5× 353 1.1× 285 1.3× 124 5.0k
W. John Edmunds United Kingdom 24 542 0.7× 1.9k 2.6× 249 0.7× 87 0.3× 180 0.8× 34 2.6k
Youngmee Jee South Korea 24 1.1k 1.4× 582 0.8× 307 0.9× 398 1.2× 151 0.7× 83 1.9k
John W. Glasser United States 22 725 0.9× 712 1.0× 182 0.5× 152 0.5× 83 0.4× 64 1.8k
Wladimir J. Alonso United States 28 1.1k 1.4× 1.8k 2.4× 162 0.5× 129 0.4× 117 0.5× 58 3.3k
Evan J. Anderson United States 38 2.1k 2.7× 2.5k 3.5× 297 0.9× 417 1.2× 250 1.1× 194 4.7k
Anthony W. Mounts United States 25 1.7k 2.2× 2.0k 2.6× 136 0.4× 265 0.8× 232 1.0× 62 3.1k
Nobuhiko Okabe Japan 31 1.8k 2.2× 1.6k 2.2× 78 0.2× 556 1.7× 109 0.5× 180 3.3k

Countries citing papers authored by Joke Bilcke

Since Specialization
Citations

This map shows the geographic impact of Joke Bilcke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke Bilcke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke Bilcke more than expected).

Fields of papers citing papers by Joke Bilcke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joke Bilcke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke Bilcke. The network helps show where Joke Bilcke may publish in the future.

Co-authorship network of co-authors of Joke Bilcke

This figure shows the co-authorship network connecting the top 25 collaborators of Joke Bilcke. A scholar is included among the top collaborators of Joke Bilcke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joke Bilcke. Joke Bilcke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manansala, Regina, Joke Bilcke, Lander Willem, Niel Hens, & Philippe Beutels. (2025). Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in Belgium. Epidemics. 51. 100826–100826.
2.
Mao, Zhuxin, Xiao Li, Ana Dacosta-Urbieta, et al.. (2023). Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. Vaccine. 41(16). 2707–2715. 29 indexed citations
3.
Antillón, Marina, Joke Bilcke, Naor Bar‐Zeev, et al.. (2023). Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study. BMC Infectious Diseases. 23(1). 3 indexed citations
4.
Li, Xiao, Joke Bilcke, Alike W. van der Velden, et al.. (2021). Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial. Clinical Drug Investigation. 41(8). 685–699. 3 indexed citations
5.
Hanquet, Germaine, Lander Willem, Heidi Theeten, et al.. (2016). Use of pneumococcal vaccines in the elderly: an economic evaluation. 2 indexed citations
6.
Hanquet, Germaine, Lander Willem, Heidi Theeten, et al.. (2016). Quelle vaccination contre le pneumocoque chez les personnes âgées ?. 1 indexed citations
7.
Ultsch, B., Oliver Damm, Philippe Beutels, et al.. (2015). Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. 34(3). 227–244. 95 indexed citations
8.
Pitzer, Virginia E., Joke Bilcke, Elisabeth Heylen, et al.. (2015). Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?. Scientific Reports. 5(1). 18585–18585. 34 indexed citations
10.
Bilcke, Joke, Samuel Coenen, & Philippe Beutels. (2014). Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All. PLoS ONE. 9(7). e102634–e102634. 50 indexed citations
11.
Beutels, Philippe, Yannick Vandendijck, Lander Willem, et al.. (2013). Seasonal influenza vaccination: prioritizing children or other target groups?. 1 indexed citations
12.
Bilcke, Joke, Albert Jan van Hoek, & Philippe Beutels. (2013). Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting?. Human Vaccines & Immunotherapeutics. 9(4). 812–822. 34 indexed citations
13.
Beutels, Philippe, Yannick Vandendijck, Lander Willem, et al.. (2013). Seasonal influenza vaccination: prioritizing children or other target groups?. 4 indexed citations
14.
Beutels, Philippe, Yannick Vandendijck, Lander Willem, et al.. (2013). Seasonal influenza vaccination: prioritizing children or other target groups?. 1 indexed citations
15.
Beutels, Philippe, Germaine Hanquet, Joke Bilcke, et al.. (2011). Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood.. 9 indexed citations
16.
Bilcke, Joke, Christiaan Marais, Albert Jan van Hoek, et al.. (2010). Kosteneffectiviteit van vaccinatie tegen windpokken bij kinderen en tegen zona bij ouderen in België. 1 indexed citations
18.
Bilcke, Joke, Philippe Beutels, Frank De Smet, et al.. (2007). Kosten-effectiviteitsanalyse van rotavirus vaccinatie van zuigelingen in België.
19.
Bilcke, Joke, Anthony Herrel, & Peter Aerts. (2007). Effect of prey- and predator size on the capture success of an aquatic snake. Belgian journal of zoology. 137(2). 191–195. 6 indexed citations
20.
Bilcke, Joke, Philippe Beutels, Frank De Smet, et al.. (2007). Cost-effectiveness analysis of rotavirus vaccination of Belgian infants. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026